Compliance to clinical guidelines determines outcome in glutaric aciduria type I in the era of newborn screening;Das einhalten klinscher richtlinien verbessert die prognose bei glutarazidurie typ 1
Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency
Hoffmann GF, etal. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 1996 27 115-123
Guidelines for the diagnosis and management of glutaryl- CoA dehydrogenase deficiency (glutaric aciduria type I)
Kölker S, etal. Guidelines for the diagnosis and management of glutaryl- CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherited Metab Dis 2007 30 5-22
Decline of acute encephalopathic crisis in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany
Kölker S, etal. Decline of acute encephalopathic crisis in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Ped Res 2007 62 357-363
Natural history, outcome and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency
Kölker S, etal. Natural history, outcome and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 2006 59 840-847
Expanded newborn screening for inborn errors of metabolism by electospray ionization-tandem mass spectrometry: Results, outcome and implications
Schulze A, etal. Expanded newborn screening for inborn errors of metabolism by electospray ionization-tandem mass spectrometry: Results, outcome and implications. Pediatrics 2003 111 1399-1406